Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 4,78€(+101,69%). Der Median liegt bei 4,78€(+101,69%).
Kaufen | 1 |
Halten | 0 |
Verkaufen | 1 |
Scoring-Modelle
Dividenden-Strategie | 3 / 15 |
HGI-Strategie | 4 / 18 |
Levermann-Strategie | -8 / 13 |
News
My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys
January saw solid investment activity with $1,500 in net capital added, primarily into Business Development Companies like Owl Rock Capital, Goldman Sachs BDC, and Blackstone Secured Lending Fund. Dividend income hit a record $814 in January, up 21% Y/Y, driven by ongoing investments in high-yield BDCs, aiming for $11,000 annual net dividends. Focus on maintaining steady BDC dividends and achieving a monthly increase of $100 in dividend income.» Mehr auf seekingalpha.com
These high-yielding REIT stocks are soaring in 2025
Real Estate Investment Trust (REIT) stocks are having a rough year as interest rates remains at an elevated level. Government bond yields have risen to near 5% and the Fed has hinted that it will deliver just two rate cuts this year.» Mehr auf invezz.com
Diversified Healthcare Trust Completes $159.0 Million Sale of MUSE Life Science Asset in San Diego, California
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced it has completed the $159.0 million sale of MUSE, a 186,000 square foot, three building life science property located in Torrey Pines, San Diego. At the time of sale, the property was 49% leased, with a weighted average lease term of over eight years. DHC plans to use the proceeds from the sale to pay down its senior secured notes due in January 2026. Chris Bilotto, President and Chief Executive Officer o.» Mehr auf businesswire.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 335,51 Mio | 0,37% |
Bruttoeinkommen | 57,42 Mio | 4,64% |
Nettoeinkommen | −88,62 Mio | 42,62% |
EBITDA | 44,61 Mio | 0,50% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 571,80 Mio€ |
Anzahl Aktien | 241,28 Mio |
52 Wochen-Hoch/Tief | 4,05€ - 1,92€ |
Dividendenrendite | 1,58% |
Dividenden TTM | 0,0373€ |
Beta | 2,16 |
KGV (PE Ratio) | −1,54 |
KGWV (PEG Ratio) | 0,18 |
KBV (PB Ratio) | 0,29 |
KUV (PS Ratio) | 0,23 |
Unternehmensprofil
DHC ist ein Real Estate Investment Trust (REIT), der in den Vereinigten Staaten medizinische Büro- und Life-Science-Immobilien, Seniorenwohngemeinschaften und Wellness-Zentren besitzt. DHC wird von der operativen Tochtergesellschaft von The RMR Group Inc. verwaltet, einer alternativen Vermögensverwaltungsgesellschaft mit Hauptsitz in Newton, MA.
Name | Diversified Healthcare Trust |
CEO | Christopher J. Bilotto |
Sitz | Newton, ma USA |
Website | |
Industrie | Diversifizierte REITs |
Börsengang | |
Mitarbeiter | 600 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | DHC |
Frankfurt | SNF.F |
München | SNF.MU |
Assets entdecken
Shareholder von Diversified Healthcare Trust investieren auch in folgende Assets